AzTrials
AzTrials

GamblingNCT01596478

Effectiveness of Therapy Treatment

A study testing Treatment as Usual, Cognitive Motivational Behavior Therapy and 12-week wait list in people with Gambling and Pathological Gambling, run by Problem Gambling Institute of Ontario at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The efficacy of psychosocial treatments for PG, including cognitive-behaviour therapy (CBT) and motivational interviewing (MI) approaches, has been supported in a handful of clinical trials. Indeed, there is more evidence supporting these two approaches than for any other psychosocial treatment for problem gambling. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Gambling, Pathological Gambling
What is being tested?
Treatment as Usual, Cognitive Motivational Behavior Therapy and 12-week wait list
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteCanada
Study dates
Dec 2011to Dec 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Main Study: Participants must score at least a 5 on the NODS, and have gambled in the previous two months. Participants must speak English and be able to provide informed consent.
  • Pilot Phase: Participants must be patients of the Problem Gambling Services at Windsor Regional Hospital.

Who cannot join

  • Main Study: Acute psychosis, mania or suicidality for which the participant needs immediate treatment, and current enrollment in formal problem gambling treatment (other than the current admission).
  • Participants with a co-occurring psychiatric or substance use condition will receive referrals to appropriate ancillary services.

Trial locations and contacts

1 site in 1 country.

Lisa Sulkowski, B.S. contact

(313) 993-3966

lsulkows@med.wayne.edu

Canada1 site, 1 recruiting
  • Windsor Regional Hospital Problem Gambling Services

    Windsor, Ontario

    David Ledgerwood, PhD

    Recruiting

Other trials in Canada

About this study

Official title: Effectiveness of Cognitive-Motivational Behaviour Therapy in Community

The efficacy of psychosocial treatments for PG, including cognitive-behaviour therapy (CBT) and motivational interviewing (MI) approaches, has been supported in a handful of clinical trials. Indeed, there is more evidence supporting these two approaches than for any other psychosocial treatment for problem gambling. However, while efficacy studies have been conducted, few studies have examined the effectiveness of behavioural treatment in community-based gambling treatment settings. That is to say, the investigators have a good idea of what works in a laboratory setting (i.e., university research settings), but the investigators have no research assessing the transfer of evidence-based treatments for problem gambling to community care. Efficacy studies provide substantially less information about the actual utility of treatments than do effectiveness trials because the way in which treatment is actually provided in the field (with flexibility in terms of time-frame and technique and the tendency to address co-occurring problems) is different from the much more single-focused (on gambling) way it is conducted in laboratory settings. The proposed study is designed to address this significant gap in the research literature. The investigators propose to conduct a treatment effectiveness trial examining a combined cognitive motivational behavior therapy (CMBT) delivered by community-based problem gambling treatment providers, compared with treatment as usual (TAU).

Read the detailed description

Pilot Study: Eligible participants will undergo a full consent process and a brief interview to assess demographics. Participants' counselors will be asked to audio-record up to 3 therapy sessions which will subsequently be rated for adherence to CMBT procedures.

Main Study: Eligible participants will undergo a full consent process followed by an in-depth interview, with a research assistant. Following an intake assessment, participants will be randomly assigned to one of the three intervention groups. Randomization also will be balanced based on gender to ensure an equitable distribution of men and women in each condition. The research assistant will give the treatment referrals and will introduce the participant to his/her therapist as appropriate.

Treatment will be provided by clinicians at the Windsor Regional Problem Gambling Services.

  • Treatment as usual (TAU) - Therapists will be instructed to conduct therapy as they normally would with PGs entering treatment.
  • Cognitive motivational behaviour therapy (CMBT) Therapy will consist of 12 60-minute individual counselling sessions. The cognitive-behavioural portion of the intervention is targeted at addressing gambling-related cognitive distortions (e.g., the idea that the gambler can control random events). Motivational interviewing techniques are included to address participant ambivalence about his/her gambling.

Approximately 8 therapists will provide treatment (4 CMBT and 4 TAU, randomly assigned using flip of a coin.) The therapists enrolled in CMBT will be trained for the study. TAU therapists will be offered training in CMBT once study recruitment goals have been met (thus, eventually all therapists will receive training in CMBT). Prior to providing treatment, therapists selected to administer CMBT will receive intensive training in administration of this approach. The therapists will be selected from the professional staff of the Windsor Regional Hospital's Problem Gambling Services.

-Waitlist control condition (WLC) - WLC participants will wait 12-weeks to begin treatment.

At that point, participants will be randomly assigned to receive TAU or CMBT and will proceed through the same study phase (i.e., treatment and follow-up).

Participants will undergo assessments at intake, post-treatment, 6- and 12-months.

Being tested
Treatment as Usual, Cognitive Motivational Behavior Therapy, 12-week wait list
Keywords
Gambling, Pathological Gambling
Medical subject headings
Gambling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment as UsualBehavioural

    Participants will receive Treatment as Usual, on an individual basis, for 60-minutes once per week for 12 weeks.

  • Cognitive Motivational Behavior TherapyBehavioural

    Participants will receive a combined motivational and cognitive-behavioral therapy, on an individual basis, for 60-minutes once per week for 12 weeks.

  • 12-week wait listBehavioural

    Participants will be randomly assigned to start treatment immediately or to go on a 12-week wait list (where they will start treatment 12 weeks from day of consent).

Study groups in NCT01596478
Study groupRoleWhat they receive
Treatment As UsualActive comparatorThe standard treatment usually provided at the clinic.
Receives: Behavioral: Treatment as Usual
Cognitive Motivational Behavior TherapyActive comparatorAn approach that addresses motivation to change gambling and behavioral patterns related to gambling.
Receives: Behavioral: Cognitive Motivational Behavior Therapy
12-week wait listActive comparatorParticipant will start treatment 12 weeks from day of consent.
Receives: Behavioral: 12-week wait list

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in pathological gambling severity through treatment

    Measured: changes in gambling severity from baseline at post-treatment

  2. Changes in problem gambling severity through follow-up

    Measured: Changes in gambling severity from post-treatment through 6-month and 12-month follow-up periods

Secondary outcomes (1)
  1. Examine putative mechanisms of action of "cognitive motivational behavior therapy" relative to "treatment as usual".

    Assess treatment motivation, coping style, cognitive distortions, psychiatric severity and gambling self-efficacy before and after treatment.

    Measured: Baseline, and changes in gambling mechanisms of action from baseline at post-treatment, 6 and 12 months after beginning treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2012 (estimated)
  2. Study startDec 2011
  3. Primary completionDec 2013 (estimated)
  4. Study completionDec 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01596478
Sponsor's protocol ID
WSU-#080211M1F
Status last verified
May 2012
First submitted
26 Apr 2012
Last updated
11 Jan 2017
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Treatment as Usual, Cognitive Motivational Behavior Therapy and 12-week wait list in people with Gambling and Pathological Gambling, run by Problem Gambling Institute of Ontario at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lisa Sulkowski, B.S. ((313) 993-3966, lsulkows@med.wayne.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in pathological gambling severity through treatment (time frame: changes in gambling severity from baseline at post-treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in